EPM speaks to Kevin Deane, vice president of Front-End Innovation and Connected Health at. Phillips-Medisize about the promise of connected health in drug delivery for patients, pharmaceutical providers, and the healthcare industry.
With the popularity for vitamins and other health products continuing to rise, manufacturers must ensure that their products are appropriately packaged in order to minimise risk states Selig’s Peter Tindale, Sales Director.
Jason Lacombe, CEO of software company Veratrak explains why the life sciences industry still needs to improve the way it manages data and the technologies that can help improve supply chains throughout pharma.
Ian Bolland speaks to Epistemic AI founders Stefano Pacifico and David Heeger about how its software can be used in drug development and the race to find a cure for Coronavirus.
Ursula Nollenberger, product line director and Kevin Ehlert, segment manager, Trelleborg Healthcare & Medical discuss the necessary steps to launching a succesful drug/device combination product.
Anil Kumar Busimi - senior global product manager for SCHOTT iQ Platform at SCHOTT, explores how innovation in packaging is giving patients more options to administer medication from home.
Vanessa Fachada Oliveira, pharmacovigilance manager & EU QPPV at Arriello, highlights key areas of focus for marketing authorisation holders to achieve an effective audit of their pharmacovigilance systems.
Abi Pesun, director at Almac ONE explains how a shift towards unified supply chain management can accelerate timelines and help mitigate risk for clinical trials during Covid-19.
In this Perspective on Pharma featureJung Doh, market development scientist at Beckman Coulter Life Sciences, explains how they entered the pharmaceutical industry after an unexpected opportunity arose.
EPM speaks to Alex Guite, vice president of Services and Alliances at World Courier about the impact Covid-19 has had on the clinical trials sector and how a direct-to-patient approach can help trials continue.
